Cambridge Cognition Holdings Plc (COG.L) Share Price & News

We optimise the assessment of cognition for better brain health research with scientifically validated digital health solutions.

Our software solutions enable gold standard cognitive research and efficient clinical trials, accelerating safe and effective treatment development, helping to improve patient outcomes in conditions affecting brain health.

We support clients in over 100 countries, including the world’s leading biotech and pharmaceutical companies and more than 800 universities worldwide.